The aetiology of paroxysmal nocturnal haemoglobinuria (PNH) is a somatic mutation in the X-linked phosphatidylinositol glycan class A gene (PIGA), resulting in global deficiency of glycosyl phosphatidylinositol-anchored proteins (GPI-APs). This study applied RNA-sequencing to examine functional effects of the PIGA mutation in human granulocytes. CXCR2 expression was increased in GPI-AP -compared to GPI-AP + granulocytes. Macrophage migration inhibitory factor, a CXCR2 agonist, was significantly higher in plasma of PNH patients. Nuclear factorjB phosphorylation was upregulated in GPI-AP À compared with GPI-AP + granulocytes. Our data suggest novel mechanisms in PNH, not obviously predicted by decreased production of the GPI moiety.
Paroxysmal nocturnal haemoglobinuria (PNH) is a life-threatening disease characterized by intravascular haemolysis, pancytopenia and venous thrombosis. PNH is an acquired clonal disorder that arises from haematopoietic stem cells (HSCs) and is caused by somatic mutations of the X-linked phosphatidylinositol glycan class A gene (PIGA), which results in global deficiency in cell surface expression of glycosyl phosphatidylinositol-anchored proteins (GPI-APs) (Takeda et al, 1993) . GPI-AP deficiency is manifest in cells of multiple haematopoietic lineages (Katagiri et al, 2013) . PNH is clinically closely related to aplastic anaemia (AA), and occurs almost exclusively in bone marrow (BM) failure associated with favourable outcome to immunosuppressive therapy (Young et al, 2006) . However, the mechanism responsible for clonal expansion of PIGA-mutant cells in BM failure is not well understood.
CXCR2, the interleukin 8 receptor, has broad functions in the pathophysiology of disease and has been a potential therapeutic target (Russo et al, 2014) . Here, we identified novel pathways in GPI-AP À granulocytes by RNA-sequencing (RNAseq), including high CXCR2 expression in GPI-AP À compared to GPI-AP + granulocytes. Increased levels of CXCR2 ligand in plasma and of its cellular receptor may lead to nuclear factor (NF)-jB activation in GPI-AP À granulocytes.
Materials and methods

Patients
Blood and BM samples were collected after written informed consent in accordance with the Declaration of Helsinki and under protocols approved by the Institutional Review Board of the National Heart, Lung, and Blood Institute (www.clinicaltrials.gov #NCT00071045). Samples from 23 PNH patients (Table SI) and 19 healthy controls were used in this study. Cell sorting was performed on the same day of blood draw. The gating strategy for sorting granulocytes is summarized in Figure S1 .
Flow cytometry and cell sorting
RNA sequencing and analysis
Quality of total RNA extracted from PNH patients and healthy controls was assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA 
Statistics
Significance was determined by one-way ANOVA and Tukey's test or by a two-tailed Student's t test using GraphPad PRISM version 6.0 (GraphPad Software Inc., San Diego, CA, USA). A P value of less than 0Á05 was considered significant. For details and additional methods, see the supplemental Methods.
Results/Discussion
For transcriptome profiling of GPI-AP + and GPI-AP À cells in PNH patients, RNA-seq was performed in GPI-AP + and GPI-AP À granulocytes from two PNH Patients 1 and 2, and GPI-AP + granulocytes from three healthy controls for screening (Table SI ; Fig S1) . Thirty genes were significantly differentially expressed, of which 18 were up-regulated (including CSF2RB, CXCR2, CXCR1 and TNFRSF10C) and 12 downregulated (including H1FX) (>2-fold change, false discovery rate [FDR] < 0Á05; Fig 1A and B) . We generated a heatmap to visualize the differences in the 30 genes (Table SII ; Fig S2) . By pathway analysis, putative gene network interactions of differentially expressed genes were significantly enriched for canonical pathways of granulocyte adhesion, diapedesis, and interleukin 8 (IL8) signalling (Fig 1C) . Gene set enrichment analysis showed "Transmembrane Receptor Activity" as one of the most upregulated pathways in GPI-AP À granulocytes (Fig S3) .
Differential cell surface expression of CXCR2, CXCR1, CSF2RB and TNFRSF10C was assessed by flow cytometry for validation, as these are important cytokine/chemokine receptors and their expression levels were higher than those of other candidate genes. We confirmed consistently higher CXCR2, CXCR1 and CSF2RB expression in GPI-AP À compared to GPI-AP + granulocytes from PNH patients and healthy controls ( Fig 1D and E, n = 11, P < 0Á05). We focused on CXCR2 (CXCR1) for further analysis, as this IL8 receptor plays a critical role in granulocyte homeostasis, especially chemotaxis (Russo et al, 2014) . CXCR2 expression on GPI-AP À granulocytes and monocytes was consistently higher than on GPI-AP + cells from PNH patients and from healthy controls (Fig 1F and G, n = 11, P < 0Á05). We found significantly higher CXCR1 expression only on GPI-AP À granulocytes (Fig 1F and G ; P < 0Á05). Confocal microscopy further validated these differences in CXCR2 expression ( Fig 1H; Fig S4) . In healthy controls, CXCR2 expression was low on HSCs and progenitors and weakly expressed on HSCs and progenitors on both GPI-AP + and GPI-AP À cells in PNH ( Fig 1I; Fig S5 , n = 6); thus, differential CXCR2 expression was evident only in differentiated myeloid cells. IL8 and other CXCL ligands, such as CXCL1, CXCL5 and macrophage migration inhibitory factor (MIF), bind to CXCR2 (Russo et al, 2014) and affect downstream pathways, typically involving NF-jB activation (Waugh & Wilson, 2008) . We evaluated ligand and cytokine levels in PNH plasma. MIF, SDF-1a (also termed CXCL12) and b-NGF levels were higher in PNH than in healthy controls (Fig 2A  and B ; Table SIII, P < 0Á05). Plasma MIF levels positively correlated with the frequency of peripheral GPI-AP À granu-
We hypothesized that increased plasma MIF in PNH and increased CXCR2 expression in GPI-AP À granulocytes lead to aberrant NF-jB activation ( Fig 2D) . pNF-jB p65 (also termed RELA) levels were higher in GPI-AP À than in GPI-AP + granulocytes in PNH, and higher in GPI-AP À and GPI-AP + granulocytes of PNH than in control granulocytes ( Fig 2E, P < 0Á05 ). AKT and ERK1/2 (also termed AKT1 and MAPK1/3, respectively), both found downstream of CXCR2 and upstream of the NF-kB pathway, were also significantly phosphorylated in GPI-AP À compared with GPI-AP + granulocytes, both from PNH patients and healthy controls (Fig 2D and F) . We first applied RNA-seq to examine the functional effects of the PIGA mutation in human granulocytes and experimentally showed that increased CXCR2 ligands in plasma and cellular receptors led to NF-jB activation. Clonal dominance in PNH might occur due to either an intrinsic growth advantage of PIGA-mutant cells (Shen et al, 2014) and/or because of cell-extrinsic factors that provide an advantageous environment (Chen et al, 2005) . CD34
+ cells from PNH patients show up-regulation of genes involved in immune responses in GPI-AP + CD34 + cells, suggesting that PIGAmutated cells escaped from immune attack (Chen et al, 2005) . CXCR2 plays a critical role in granulocyte homeostasis, especially chemotaxis (Russo et al, 2014) . CXCR2 is upregulated on CD34 + cells of patients with myelodysplastic syndromes (MDS), and blocking the IL8/CXCR2 pathway has been proposed to target MDS/acute myeloid leukaemia (AML) stem cells and solid tumours (Waugh & Wilson, 2008; Schinke et al, 2015) . As CXCR2 ligands affect NF-jB activation in various cancer cells and promote cell survival, PIGA-deficient K562 cells show profound defects in membrane lipid raft formation, and proper lipid-raft formation regulates CXCR4/SDF-1a-mediated adhesion of normal HSCs in BM, a mechanism crucial for BM retention of the cells (Ratajczak et al, 2012) . Release-inducing CXCR2 signals and retention-promoting CXCR4 signals act antagonistically to regulate neutrophil release from BM (Eash et al, 2010) . Regulation by CXCR2 and CXCR4 is reciprocal, and our data could explain why granulocyte colony-stimulating factor administration preferentially mobilizes GPI-AP À cells (Johnson et al, 1998) . In a recent study, CXCR2-deficient HSCs/ progenitor cells exhibited reduced self-renewal capacity as measured in serial transplantation assays (Sinclair et al, 2016) . MIF, a functional noncognate ligand for CXCR2 and CXCR4, controls inflammatory leucocyte recruitment (Bernhagen et al, 2007) . MIF is present in erythrocytes and induces biological outcomes in haemolytic disorders (Mizue et al, 2000) . Positive correlation between MIF levels and the frequency of GPI-AP À granulocytes is consistent with recruitment of GPI-AP À granulocytes by MIF.
1However, our data do not explain the mechanism of growth advantage of GPI-AP À HSCs over normal HSCs in BM. We examined granulocytes because GPI-AP À cells are abundant in mature myeloid populations in peripheral blood, allowing sufficient cell numbers for bulk RNA-seq. Single-cell RNA-seq profiles cell-to-cell variability and is applicable to HSCs in future studies. Deficiency of CD14, a GPI-AP, leads to increased CXCR2 expression in mice (Echchannaoui et al, 2005) , and it might be a mechanism of increased CXCR2 expression in humans (Fig S6) . However, CD14 expression levels could not fully explain the differential expression of CXCR2 between GPI-AP + and GPI-AP À cells.
An explanatory molecular mechanism might involve another GPI-AP in granulocytes. We could not examine serial samples before and after treatment with eculizumab, but flow cytometry showed no significant differences in CXCR2 expression between patients receiving eculizumab and those on no therapy (data not shown).
In conclusion, we identified novel pathways associated with GPI-AP À granulocytes by RNA-seq and validated higher CXCR2 expression in GPI-AP À than GPI-AP + granulocytes.
Increased levels of CXCR2 ligand and cellular receptor led to NF-jB activation in GPI-AP À granulocytes. Our data suggest novel pathophysiological mechanisms in PNH, not obviously predicted by decreased production of GPI-APs.
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